427 related articles for article (PubMed ID: 25104798)
1. Mast cells as effectors in atherosclerosis.
Bot I; Shi GP; Kovanen PT
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):265-71. PubMed ID: 25104798
[TBL] [Abstract][Full Text] [Related]
2. Mast cells in atherosclerosis.
Bot I; Biessen EA
Thromb Haemost; 2011 Nov; 106(5):820-6. PubMed ID: 21866302
[TBL] [Abstract][Full Text] [Related]
3. The role of mast cells in atherosclerosis.
Wezel A; Quax PH; Kuiper J; Bot I
Hamostaseologie; 2015; 35(2):113-20. PubMed ID: 25377048
[TBL] [Abstract][Full Text] [Related]
4. IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles.
Taleb S; Tedgui A; Mallat Z
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):258-64. PubMed ID: 25234818
[TBL] [Abstract][Full Text] [Related]
5. Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties.
Nguyen SD; Maaninka K; Lappalainen J; Nurmi K; Metso J; Öörni K; Navab M; Fogelman AM; Jauhiainen M; Lee-Rueckert M; Kovanen PT
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):274-84. PubMed ID: 26681753
[TBL] [Abstract][Full Text] [Related]
6. Mast cells mediate neutrophil recruitment during atherosclerotic plaque progression.
Wezel A; Lagraauw HM; van der Velden D; de Jager SC; Quax PH; Kuiper J; Bot I
Atherosclerosis; 2015 Aug; 241(2):289-96. PubMed ID: 26062988
[TBL] [Abstract][Full Text] [Related]
7. Inflammation and atherosclerosis: what is on the horizon?
Ruparelia N; Choudhury R
Heart; 2020 Jan; 106(1):80-85. PubMed ID: 31843811
[No Abstract] [Full Text] [Related]
8. Mast cells emerge as mediators of atherosclerosis: Special emphasis on IL-37 inhibition.
Conti P; Lessiani G; Kritas SK; Ronconi G; Caraffa A; Theoharides TC
Tissue Cell; 2017 Jun; 49(3):393-400. PubMed ID: 28420489
[TBL] [Abstract][Full Text] [Related]
9. Exploring immune checkpoints as potential therapeutic targets in atherosclerosis.
Kusters PJH; Lutgens E; Seijkens TTP
Cardiovasc Res; 2018 Mar; 114(3):368-377. PubMed ID: 29309533
[TBL] [Abstract][Full Text] [Related]
10. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions.
Raggi P; Genest J; Giles JT; Rayner KJ; Dwivedi G; Beanlands RS; Gupta M
Atherosclerosis; 2018 Sep; 276():98-108. PubMed ID: 30055326
[TBL] [Abstract][Full Text] [Related]
11. The role of inflammation and allergy in acute coronary syndromes.
Ozben B; Erdogan O
Inflamm Allergy Drug Targets; 2008 Sep; 7(3):136-44. PubMed ID: 18782020
[TBL] [Abstract][Full Text] [Related]
12. Impact of capsaicin on mast cell inflammation.
Frydas S; Varvara G; Murmura G; Saggini A; Caraffa A; Antinolfi P; Tete' S; Tripodi D; Conti F; Cianchetti E; Toniato E; Rosati M; Speranza L; Pantalone A; Saggini R; Di Tommaso LM; Theoharides TC; Conti P; Pandolfi F
Int J Immunopathol Pharmacol; 2013; 26(3):597-600. PubMed ID: 24067456
[TBL] [Abstract][Full Text] [Related]
13. Mast cells and metabolic syndrome.
Zhang J; Shi GP
Biochim Biophys Acta; 2012 Jan; 1822(1):14-20. PubMed ID: 21185370
[TBL] [Abstract][Full Text] [Related]
14. Editorial: update on inflammatory targets modulating atherogenesis.
Carbone F; Mach F; Montecucco F
Curr Drug Targets; 2015; 16(4):282-3. PubMed ID: 25859799
[No Abstract] [Full Text] [Related]
15. Mast cells: a novel therapeutic avenue for cardiovascular diseases?
Poto R; Marone G; Galli SJ; Varricchi G
Cardiovasc Res; 2024 May; 120(7):681-698. PubMed ID: 38630620
[TBL] [Abstract][Full Text] [Related]
16. Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect.
Fredman G; MacNamara KC
Cardiovasc Res; 2021 Nov; 117(13):2563-2574. PubMed ID: 34609505
[TBL] [Abstract][Full Text] [Related]
17. Macrophages and dendritic cells: the usual suspects in atherogenesis.
Kassiteridi C; Monaco C
Curr Drug Targets; 2015; 16(4):373-82. PubMed ID: 25808566
[TBL] [Abstract][Full Text] [Related]
18. Mast cells in atherosclerotic cardiovascular disease - Activators and actions.
Kovanen PT; Bot I
Eur J Pharmacol; 2017 Dec; 816():37-46. PubMed ID: 29032103
[TBL] [Abstract][Full Text] [Related]
19. Chymase activity is closely related with plaque vulnerability in a hamster model of atherosclerosis.
Guo T; Chen WQ; Zhang C; Zhao YX; Zhang Y
Atherosclerosis; 2009 Nov; 207(1):59-67. PubMed ID: 19446292
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in therapeutic targeting of inflammation in atherosclerosis.
Hedin U; Matic LP
J Vasc Surg; 2019 Mar; 69(3):944-951. PubMed ID: 30591299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
